cancer sequencing Jun 24, 2022 Molecular Tumor Profiling Benefits Pediatric Cancer Patients, Study Finds Apr 21, 2022 New Mutational Signatures Detected in Cancers Profiled for UK's 100K Genomes Project Mar 29, 2022 Thermo Fisher Scientific Obtains CE Mark for Ion Torrent Genexus Dx Integrated Sequencer Feb 17, 2022 Mass General, Lunaphore Technologies to Develop Test to Predict PARP Inhibitor Response Feb 11, 2022 Cancer Genome Analysis Points to Biallelic Mutations to Inform Variant Interpretation Feb 9, 2022 Large-Scale Cancer Genome Analysis Reveals Mutation Clusters That Can Inform Prognosis Dec 14, 2021 BostonGene Partners with NEC to Offer Tumor Portrait Tests Internationally Mar 3, 2021 Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers Premium Feb 17, 2021 Exact Sciences Sketches Out Strategy for End-to-End Cancer Testing With Ashion Acquisition Premium Feb 2, 2021 Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Nov 24, 2020 Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves Premium Sep 16, 2020 LabCorp's Covance Joins Tempus TIME Trial Program Aug 6, 2020 Adaptive Biotechnologies Receives Expanded FDA Clearance for ClonoSeq MRD Assay Jul 15, 2020 Patient Education Project Identifies Need for Consistent Terms in Cancer Testing Premium Jul 8, 2020 Thermo Fisher Scientific, Chugai Pharmaceutical Sign Companion Diagnostic Agreement for NSCLC Jun 11, 2020 Thermo Fisher Scientific, Genetron Health Partner on NGS-Based Cancer Dx in China May 27, 2020 Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics Apr 28, 2020 Caris Life Sciences Seeks FDA Approval for Exome, Transcriptome CDx Assays Apr 21, 2020 ArcherDx, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
